Behind every care companion is an opportunity to reshape how the world approaches neurodegeneration.
Ojas is building compassionate intelligence for neurodegenerative care — starting with Parkinson's disease, the fastest-growing neurological condition in the world. We're looking for investors, clinicians, and research partners who share our vision.
Between clinic visits, hundreds of millions of people are invisible to the healthcare system.
Neurodegenerative conditions affect over 60 million people worldwide, with numbers rising sharply as populations age. Yet the care model hasn't changed: a 15-minute appointment every 3–6 months — during which a clinician must assess conditions that fluctuate hour to hour.
No one is capturing what actually happens between visits. That data — real, longitudinal, from both patient and caregiver — doesn't exist today.
Not another tracker. A fundamentally different architecture.
Caregiver Role
Co-primary user with equal input validity
Secondary or absent
Device Requirement
Any smartphone — no wearable needed
Most require Apple Watch + prescription
Comorbidity Awareness
Explicitly tracked and modeled
Ignored or treated as noise
Sex/Gender Intelligence
Adaptive experience by sex, hormones, life-stage
One-size-fits-all
Design Philosophy
Care-first, fear-free, dignity-preserving
Data-extraction focused
Data Architecture
Signal-first — built for longitudinal ML from day one
Retrofitted analytics
Parkinson's is the entry point, not the ceiling.
The signal-first architecture is designed to serve the full neurodegenerative spectrum — MS, Alzheimer's, Essential Tremor, ALS — each with similarly underserved patient-caregiver populations.
Not a slide deck. A working product with real architecture.
Functional Product
13+ screens across patient & caregiver flows — not a prototype
Cross-Platform Stack
React Native (Expo) + Supabase — local-first, cloud-synced
Nurture Module
Guided breathing, voice, and walking sessions live in-app
Design System
Custom accessibility-first design with WCAG 2.5.8 compliance
Intelligence Pipeline
Automated Reddit qualitative research mining patient communities
Clinical Research
Primary interviews — neurologists, patients, caregivers (US, India, France)
Company Registration
SAS in France — incorporation in progress
Content Strategy
Comprehensive plan spanning clinical education & caregiver support
B2B2C hybrid with three revenue layers.
Free tier ensures global reach. EU premium tier establishes revenue from day one. Clinic pilots convert to contracts. Payer deals unlock scaled institutional revenue.
Consumer Premium
Advanced insights, full clinical exports, caregiver alerts
€4–9/monthClinic Licensing
Multi-patient dashboard, enhanced clinical reporting
€50–150/clinic/monthPayer Contracts
Value-based per-patient-per-month institutional revenue
€30–50 PMPMBreak-even at ~26,000 users. >85% gross margin at scale.
| Year | Active Users | Revenue | Key Milestone |
|---|---|---|---|
| Y1 | 3,000 | €29K | France launch, first clinic pilots |
| Y2 | 15,000 | €188K | EU expansion, US market entry |
| Y3 | 50,000 | €682K | Payer contract validation, breakeven |
| Y4 | 120,000 | €1.9M | India volume expansion, DTx prep |
| Y5 | 250,000 | €4.7M | Multi-market scale, regulatory submission |
Execution capability rooted in lived experience.
Varun Singh
Varun has spent over a decade and a half across management consulting, enterprise growth, and product systems thinking, and has led teams at organizations including upGrad, Stack Overflow, and Times Bridge. At Ojas, he focuses on turning complex systems into simple, supportive tools for patients, caregivers, and clinicians. This mission is driven by lived caregiver experience: after 12 years caring for his father through Parkinson's, Varun set out to bridge the gap between what care is today, and what it could be for neurodegenerative patients. That became the start of Ojas.
Anupama Mishra
A strategy and partnerships leader with a global footprint, Anupama's experience spans India, Europe, and North America. She has led market entry, brand building, and ecosystem development across work connected to Headspace, Malaria No More, Disney+Hotstar, Times Bridge, and Deloitte. While completing her MBA in Paris, she co-founded Ojas and now focuses on growth, partnerships, and helping the company communicate clearly with users, partners, and funders.
“The most reliable observer of a neurodegenerative patient's daily reality is often not the patient — it's the caregiver standing next to them. Ojas is the first system designed around this truth.”
Whether you're an investor who sees the market opportunity, a clinician who lives the care gap every day, or a researcher interested in longitudinal neurodegenerative data — we'd love to talk.